CCP Podcast 050: LeoPARDS Trial

 December 31

by Jonathan Downham

Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis

Gavin and I try to peel apart the layers of the LeoPARDS Trial which assesses the benefits of levosimendan for the prevention of organ dysfunction in sepsis. It's another interesting study which actually asks more questions that it answers, but all questions we may try to answer one day with more research.

I am still hoping to get together with Danni Bear the dietician in the near future to talk about the latest findings from ASPEN. Watch this space.

Interview Questions for Advanced Critical Care Practitioners

The Content on the website is provided for FREE as is the podcast.

You could help support this work by going to Amazon via this link. This means that I will earn a small commission from any purchases you make with NO extra cost to yourself.

Thank you.

Amazon Link

[table id=1 /] [Stitcher_Radio_Logo] [get_in_touch_with_jonathan]  

share this

Related Posts

Hemotion vs Train Trials

Neuro ICU Transfusion Thresholds: HEMOTION vs TRAIN and the Case for a 90 g/L TargetI review why the standard restrictive ICU transfusion trigger of 70 g/L may fail in acute brain injury, where autoregulation is impaired, intracranial pressure is elevated, and vulnerable penumbral tissue is prone to hypoxia. I walk through two major RCTs: HEMOTION (742

Read More

Decompensated Alcohol Related Liver Disease Part 2

We return to our 48-year-old patient: jaundiced, hypotensive, drowsy, and bleeding. In decompensated cirrhosis, every treatment targets a disrupted system — splanchnic vasodilation, portal hypertension, toxin accumulation, and renal hypoperfusion.Although these patients look fluid overloaded, they are effectively hypovolaemic. Start with small aliquots of balanced crystalloid, avoiding 0.9% saline. In hepatorenal syndrome or tense ascites, 20% albumin is

Read More